HomeCompareHTEC vs MRK

HTEC vs MRK: Dividend Comparison 2026

HTEC yields 1.05% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $9.6K in total portfolio value
10 years
HTEC
HTEC
● Live price
1.05%
Share price
$32.84
Annual div
$0.35
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$112.92
Full HTEC calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — HTEC vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTECMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTEC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTEC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTEC
Annual income on $10K today (after 15% tax)
$89.63/yr
After 10yr DRIP, annual income (after tax)
$95.98/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $711.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTEC + MRK for your $10,000?

HTEC: 50%MRK: 50%
100% MRK50/50100% HTEC
Portfolio after 10yr
$26.0K
Annual income
$531.61/yr
Blended yield
2.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HTEC
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTEC buys
0
MRK buys
0
No recent congressional trades found for HTEC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTECMRK
Forward yield1.05%3.25%
Annual dividend / share$0.35$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$21.2K$30.7K
Annual income after 10y$112.92$950.29
Total dividends collected$1.1K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HTEC vs MRK ($10,000, DRIP)

YearHTEC PortfolioHTEC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,805$105.45$11,192$351.54$387.00MRK
2$11,668$106.49$12,524$392.70$856.00MRK
3$12,593$107.47$14,015$438.65$1.4KMRK
4$13,582$108.39$15,682$489.96$2.1KMRK
5$14,642$109.26$17,547$547.23$2.9KMRK
6$15,778$110.09$19,632$611.16$3.9KMRK
7$16,993$110.86$21,963$682.53$5.0KMRK
8$18,294$111.59$24,571$762.18$6.3KMRK
9$19,687$112.27$27,486$851.08$7.8KMRK
10$21,178$112.92$30,745$950.29$9.6KMRK

HTEC vs MRK: Complete Analysis 2026

HTECStock

The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.

Full HTEC Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this HTEC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTEC vs SCHDHTEC vs JEPIHTEC vs OHTEC vs KOHTEC vs MAINHTEC vs JNJHTEC vs ABBVHTEC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.